Alkermes plc
ALKS
Ранг среди акций
#2634
Alkermes plc, a biopharmaceutical company, engages in the research,... Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Цена акции
$43.05
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$7.22B
Изменение (1 день)
4.43%
Изменение (1 год)
38.95%
Страна
IE
Торговля Alkermes plc (ALKS)
Категория
Healthcare
Количество находящихся в обращении акций Alkermes plc (ALKS)
Количество акций в обращении на June 2026: 166.61M
Согласно последним финансовым отчетам и цене акций Alkermes plc, текущее количество акций в обращении составляет 166.61M. На конец December 2023 у компании было 166.22M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Alkermes plc (ALKS) с 2000 по 2026
Акции в обращении на конец каждого года
| Год | Акции в обращении | Изменить |
|---|---|---|
| 2026 (TTM) | 166.61M | 0.74% |
| 2024 | 165.39M | -0.50% |
| 2023 | 166.22M | 1.52% |
| 2022 | 163.74M | 1.74% |
| 2021 | 160.94M | 1.35% |
| 2020 | 158.80M | 1.12% |
| 2019 | 157.05M | 1.25% |
| 2018 | 155.11M | 1.11% |
| 2017 | 153.42M | 1.27% |
| 2016 | 151.48M | 1.53% |
| 2015 | 149.21M | 2.71% |
| 2014 | 145.27M | 10.30% |
| 2013 | 131.71M | 0.00% |
| 2012 | 131.71M | 14.83% |
| 2011 | 114.70M | 19.97% |
| 2010 | 95.61M | 0.81% |
| 2009 | 94.84M | -0.34% |
| 2008 | 95.16M | -5.54% |
| 2007 | 100.74M | 1.51% |
| 2006 | 99.24M | 9.03% |
| 2005 | 91.02M | 1.03% |
| 2004 | 90.09M | 9.76% |
| 2003 | 82.08M | 27.52% |
| 2002 | 64.37M | 1.10% |
| 2001 | 63.67M | 14.21% |
| 2000 | 55.75M | 0.00% |
Акции в обращении у аналогичных компаний или конкурентов
| Компания | Акции в обращении | Разница | Страна |
|---|---|---|---|
| 253.90M | 52.39% |
US
|
|
| 396.00M | 137.68% |
US
|
|
| 478.91M | 187.44% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -62.68% |
NL
|
